BoxGroup
BoxGroup Services, LLC is a venture capital firm based in New York City, founded in 2009. It specializes in early-stage investments, primarily focusing on pre-seed, seed, and early Series A rounds. The firm targets a variety of sectors, including disruptive technology, healthcare, biotech, food, software as a service, e-commerce, and fintech. BoxGroup typically invests between $50,000 and $500,000 in each company, emphasizing a conviction in the founding team and their vision to create category-defining businesses. Although it primarily invests in New York City, Silicon Valley, and Los Angeles, the firm is open to opportunities globally. Notably, BoxGroup does not take board seats or ownership stakes in the companies it supports.
Goose provides software solutions specifically designed for pet care businesses to enhance customer experiences and increase revenue. The company's platform offers innovative tools for pet boarding providers, streamlining operations and boosting client satisfaction. oose focuses on improving operational efficiency and customer convenience in the pet care industry, aiming for substantial revenue growth.
Pomelo Care
Series B in 2024
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and their infant’s first year. The company combines virtual, round-the-clock clinical care with in-person doula services to create a unique support model that effectively addresses medical, behavioral, and social factors influencing maternal and infant health. By leveraging data science and machine learning, Pomelo identifies and manages risks associated with pregnancy and postpartum care, aiming to enhance health outcomes while reducing unnecessary costs. The platform provides personalized care plans and resources to meet the specific needs of pregnant individuals and newborns, collaborating with employers as well as commercial and Medicaid health plans to promote accessible and high-quality care.
Loyal is a biotechnology company focused on developing veterinary pharmaceuticals aimed at extending the lifespan and improving the health span of dogs. By creating medications that target the aging process, Loyal seeks to delay or prevent the onset of age-related diseases, including cancer, heart disease, and metabolic disorders. The company's innovative approach involves quantifying and regulating the biological processes associated with aging, which helps to mitigate the severity of these ailments. Through its research and product development, Loyal strives to ensure that dogs can enjoy longer, healthier lives, ultimately benefiting both pets and their owners.
Pomelo Care
Series A in 2023
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and their infant’s first year. The company combines virtual, round-the-clock clinical care with in-person doula services to create a unique support model that effectively addresses medical, behavioral, and social factors influencing maternal and infant health. By leveraging data science and machine learning, Pomelo identifies and manages risks associated with pregnancy and postpartum care, aiming to enhance health outcomes while reducing unnecessary costs. The platform provides personalized care plans and resources to meet the specific needs of pregnant individuals and newborns, collaborating with employers as well as commercial and Medicaid health plans to promote accessible and high-quality care.
Sundays for Dogs
Series A in 2022
Sundays for Dogs, Inc. is a New York-based company that specializes in the manufacture and online retail of dog foods. Founded in 2017 by Tory Waxman and Michael Waxman, the company utilizes a unique air-drying method to produce its products. This technique gently dehydrates the food at low temperatures, ensuring that nutrients and flavors are preserved while effectively eliminating harmful germs. By focusing on high-quality ingredients and innovative production methods, Sundays for Dogs aims to provide pet owners with nutritious and flavorful options for their dogs.
Loyal is a biotechnology company focused on developing veterinary pharmaceuticals aimed at extending the lifespan and improving the health span of dogs. By creating medications that target the aging process, Loyal seeks to delay or prevent the onset of age-related diseases, including cancer, heart disease, and metabolic disorders. The company's innovative approach involves quantifying and regulating the biological processes associated with aging, which helps to mitigate the severity of these ailments. Through its research and product development, Loyal strives to ensure that dogs can enjoy longer, healthier lives, ultimately benefiting both pets and their owners.
Pomelo Care
Seed Round in 2021
Pomelo Care is a leader in evidence-based maternity care, offering comprehensive support for women throughout preconception, pregnancy, birth, postpartum, and their infant’s first year. The company combines virtual, round-the-clock clinical care with in-person doula services to create a unique support model that effectively addresses medical, behavioral, and social factors influencing maternal and infant health. By leveraging data science and machine learning, Pomelo identifies and manages risks associated with pregnancy and postpartum care, aiming to enhance health outcomes while reducing unnecessary costs. The platform provides personalized care plans and resources to meet the specific needs of pregnant individuals and newborns, collaborating with employers as well as commercial and Medicaid health plans to promote accessible and high-quality care.
Celevity
Seed Round in 2020
Celevity is a seed-stage company that develops drugs to help dogs live longer, healthier lives. It sees aging as a disease that is able to be slowed and improved with medicines. It was spun out of Laura Deming’s The Longevity Fund. Celevity is headquartered in San Francisco, California.
Loyal is a biotechnology company focused on developing veterinary pharmaceuticals aimed at extending the lifespan and improving the health span of dogs. By creating medications that target the aging process, Loyal seeks to delay or prevent the onset of age-related diseases, including cancer, heart disease, and metabolic disorders. The company's innovative approach involves quantifying and regulating the biological processes associated with aging, which helps to mitigate the severity of these ailments. Through its research and product development, Loyal strives to ensure that dogs can enjoy longer, healthier lives, ultimately benefiting both pets and their owners.
Modern Animal
Seed Round in 2019
Modern Animal, Inc. is a veterinary clinic and innovative veterinary platform based in Los Angeles, California, founded in 2018. The company focuses on enhancing pet care through technology, offering a range of services including wellness exams, surgery, dentistry, ultrasound, radiology, diagnostics, and emergency care. Modern Animal provides a membership model that grants clients unlimited exams and access to 24/7 virtual care, as well as in-app prescription requests and delivery. The platform is designed to improve the overall experience for pet owners and their animals by facilitating convenient appointments, telemedicine consultations, and online medical records. By combining state-of-the-art technology with personalized care, Modern Animal aims to reshape the traditional veterinary industry to better serve pets, their owners, and veterinary practitioners.
Good Dog
Seed Round in 2019
Good Dog makes it simple for people to get dogs from good sources and for reputable breeders, shelters and rescues to put their dogs in good homes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.